{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:37:06Z","timestamp":1769103426673,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National Commision of Science and Technnology","award":["NCST\/5\/003\/3rd CALL PhD\/181"],"award-info":[{"award-number":["NCST\/5\/003\/3rd CALL PhD\/181"]}]},{"name":"Kenyatta University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2719-8","type":"journal-article","created":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T00:19:54Z","timestamp":1505521194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya \u2013 a cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Florence Nafula","family":"Okwara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Paul","family":"Oyore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred Nabwire","family":"Were","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samson","family":"Gwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,16]]},"reference":[{"key":"2719_CR1","volume-title":"Global tuberculosis report 2016","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global tuberculosis report 2016. Geneva: WHO; 2016."},{"key":"2719_CR2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/adc.80.5.433","volume":"80","author":"A Rie Van","year":"1999","unstructured":"Van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in South Africa: burden and risk factor. Arch Dis Child. 1999;80:433\u20137.","journal-title":"Arch Dis Child"},{"key":"2719_CR3","first-page":"392","volume":"8","author":"BJ Marais","year":"2004","unstructured":"Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392\u2013402.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2719_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(97)70120-3","volume":"131","author":"S Smith","year":"1997","unstructured":"Smith S, Jacobs RF, Wilson CB. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr. 1997;131:16\u201326.","journal-title":"J Pediatr"},{"key":"2719_CR5","volume-title":"Interventions for tuberculosis control and elimination","author":"HL Rieder","year":"2002","unstructured":"Rieder HL. Interventions for tuberculosis control and elimination. Paris: International Union Against Tuberculosis and Lung Diseases; 2002."},{"key":"2719_CR6","unstructured":"World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. 2012. WHO\/HTM\/TB\/2012.9."},{"key":"2719_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJMe1105555","volume":"365","author":"EA Nardell","year":"2011","unstructured":"Nardell EA, Churchyard G. What is thwarting tuberculosis prevention in high-burden settings? N Engl J Med. 2011;365:79\u201381.","journal-title":"N Engl J Med"},{"key":"2719_CR8","first-page":"225","volume":"12","author":"MF Cotton","year":"2009","unstructured":"Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S, PACTG 1041 Team. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis. 2009;12:225\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2719_CR9","first-page":"821","volume":"85","author":"FW Mount","year":"1962","unstructured":"Mount FW, Ferebee SH. The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis. Am Rev Respir Dis. 1962;85:821\u20137.","journal-title":"Am Rev Respir Dis"},{"key":"2719_CR10","first-page":"490","volume":"85","author":"SH Ferebee","year":"1962","unstructured":"Ferebee SH, Mount FW. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis. 1962;85:490\u2013510.","journal-title":"Am Rev Respir Dis"},{"key":"2719_CR11","first-page":"CD001363","volume":"2","author":"MJ Smieja","year":"2000","unstructured":"Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000;2:CD001363.","journal-title":"Cochrane Database Syst Rev"},{"key":"2719_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2334-14-91","volume":"14","author":"J Ayieko","year":"2014","unstructured":"Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta\u2013analysis. BMC Infect Dis. 2014;14:91. doi: 10.1186\/1471-2334-14-91 .","journal-title":"BMC Infect Dis"},{"key":"2719_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1011214","volume":"365","author":"SA Madhi","year":"2011","unstructured":"Madhi SA, Nachman S, Violari A, Kim S, Cotton MF, Bobat R, et al. Primary Isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med. 2011;365:21\u201331. doi: 10.1056\/NEJMoa1011214 .","journal-title":"N Engl J Med"},{"key":"2719_CR14","doi-asserted-by":"crossref","unstructured":"Jaganath D, Zalwango S, Okware B, Nsereko M, Kisingo H, Malone L, et al. Contact investigation for active tuberculosis among child contacts in Uganda. Clin Infect Dis. 57(12):1685\u201392.","DOI":"10.1093\/cid\/cit645"},{"key":"2719_CR15","unstructured":"The Ministry of Public health and sanitation, Kenya,\u00a0 Division of Leprosy, Tuberculosis, and lung Diseases Guidelines on management of Leprosy and tuberculosis: Diagnosis of Tuberculosis in Children. 2010."},{"key":"2719_CR16","unstructured":"CDC Tuberculosis Publications & Products Fact Sheets Testing & Diagnosis Fact Sheets . Accessed at https:\/\/www.cdc.gov\/tb\/publications\/default.htm . Accessed 3 Dec 2016."},{"key":"2719_CR17","doi-asserted-by":"publisher","unstructured":"Jung S-H. Stratified Fisher\u2019s exact test and its sample size calculation. Biom J. 2014;56(1) doi: 10.1002\/bimj.20100048 .","DOI":"10.1002\/bimj.20100048"},{"key":"2719_CR18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/infdis\/jis608","volume":"206","author":"D Jaganath","year":"2012","unstructured":"Jaganath D, Mupere E. Childhood tuberculosis and malnutrition. J Infect Dis. 2012;206:1809\u201315.","journal-title":"J Infect Dis"},{"key":"2719_CR19","volume-title":"Tuberculosis: a comprehensive international approach","author":"DL Cohn","year":"2000","unstructured":"Cohn DL, El-Sadr WM. Treatment of latent tuberculosis infection. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker, Inc.; 2000."},{"issue":"Suppl. 1","key":"2719_CR20","first-page":"S181","volume":"6","author":"AC Hesseling","year":"2002","unstructured":"Hesseling AC, et al. The clinical features and outcome of confirmed tuberculosis (TB) in human immunodeficiency virus (HIV) infected children. Int J Tuberc Lung Dis. 2002;6(Suppl. 1):S181.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2719_CR21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39000.486400.55","volume":"334","author":"HJ Zar","year":"2007","unstructured":"Zar HJ, Cotton MF, Strauss S, Karpakis J, Hussey G, Schaaf HS, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomized controlled trial. BMJ. 2007;334:136\u201342.","journal-title":"BMJ"},{"key":"2719_CR22","doi-asserted-by":"crossref","unstructured":"Singh J. The ethics of national tuberculosis programs in low income countries not rolling out Xpert MTB\/RIF. Int J Tuberc Lung Dis. 2011;1563 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22118160","DOI":"10.5588\/ijtld.11.0728"},{"key":"2719_CR23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJMoa1005136","volume":"365","author":"NA Martinson","year":"2011","unstructured":"Martinson NA, Barnes GL, Moulton HL, Masandiwa R, Hausler H, Ram M, et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med. 2011;365:79\u201381.","journal-title":"N Engl J Med"},{"key":"2719_CR24","unstructured":"Simon Schaaf H, \u00a0Alimuddin Zuml. Human host factors which determine vulerability. In: Tuberculosis E-Book: A Comprehensive Clinical Reference, Elsevier Health Sciences, 24 Mar 2009."},{"issue":"1","key":"2719_CR25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/595012","volume":"48","author":"AC Hesseling","year":"2008","unstructured":"Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a south African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis. 2008;48(1):108\u201314.","journal-title":"Clin Infect Dis"},{"key":"2719_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/004947559702700307","volume":"27","author":"JE Garay","year":"1997","unstructured":"Garay JE. Clinical presentation of pulmonary tuberculosis in under 10s and differences in AIDS-related cases: a cohort study of 115 patients. Trop Dr. 1997;27:139\u201342.","journal-title":"Trop Dr"},{"key":"2719_CR27","first-page":"991","volume":"117","author":"DE Kopanoff","year":"1978","unstructured":"Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: a US public health service cooperative surveillance study. Am Rev Respir Dis. 1978;117:991\u20131001.","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"2719_CR28","first-page":"555","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","unstructured":"International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventative therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60(4):555\u201364.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"2719_CR29","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1371\/journal.pmed.0040238","volume":"4","author":"SA Munro","year":"2007","unstructured":"Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238.","journal-title":"PLoS Med"},{"key":"2719_CR30","first-page":"28","volume":"26","author":"SH Ferebee","year":"1970","unstructured":"Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28\u2013106.","journal-title":"Bibl Tuberc"},{"issue":"9","key":"2719_CR31","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/adc.2006.097220","volume":"91","author":"BJ Marais","year":"2006","unstructured":"Marais BJ, van Zyl S, Schaaf HS, van Aardt M, Gie RP, Beyers N. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child. 2006;91(9):762\u20135.","journal-title":"Arch Dis Child"},{"key":"2719_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-6-97","volume":"6","author":"TA Szakacs","year":"2006","unstructured":"Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, et al. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis. 2006;6:97.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2719_CR33","first-page":"13","volume":"10","author":"S Zyl van","year":"2006","unstructured":"van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis. 2006;10(1):13\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"2719_CR34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/09540120120063241","volume":"13","author":"RG Steele","year":"2001","unstructured":"Steele RG, Anderson B, Rindel B, Dreyer ML, Perrin K, Christensen R, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13(5):617\u201329.","journal-title":"AIDS Care"},{"issue":"Suppl 1","key":"2719_CR35","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","volume":"43","author":"KM Berg","year":"2006","unstructured":"Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79\u201387.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2719_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1741-7015-7-67","volume":"7","author":"SM Roux le","year":"2009","unstructured":"le Roux SM, Cotton MF, Golub JE, le Roux DM, Workman L, Zar HJ. Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules. BMC Med. 2009;7:67. doi: 10.1186\/1741-7015-7-67 .","journal-title":"BMC Med"},{"issue":"6","key":"2719_CR37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/jama.296.6.679","volume":"296","author":"EJ Mills","year":"2006","unstructured":"Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679\u201390.","journal-title":"JAMA"},{"issue":"8","key":"2719_CR38","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/INF.0b013e31816dd325","volume":"27","author":"RC Vreeman","year":"2008","unstructured":"Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686\u201391.","journal-title":"Pediatr Infect Dis J"},{"key":"2719_CR39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(08)70071-9","volume":"8","author":"J Morrison","year":"2008","unstructured":"Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low- income and middle-income countries: a systematic review and meta- analysis. Lancet Infect Dis. 2008;8:359\u201368.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"2719_CR40","doi-asserted-by":"crossref","first-page":"e0129135","DOI":"10.1371\/journal.pone.0129135","volume":"10","author":"D Assefa","year":"2015","unstructured":"Assefa D, Klinkenberg E, Yosef G. Cross sectional study evaluating routine contact investigation in Addis Ababa, Ethiopia: a missed opportunity to prevent tuberculosis in children. PLoS One. 2015;10(6):e0129135. Published online 2015 Jun 17. doi: 10.1371\/journal.pone.0129135. PMCID: PMC4470906","journal-title":"PLoS One"},{"key":"2719_CR41","volume-title":"Guidelines for intensive tuberculosis case finding and Isoniazid preventive therapy for people living with HIV in resource-constrained settings","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Guidelines for intensive tuberculosis case finding and Isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: WHO; 2011."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T15:12:37Z","timestamp":1570115557000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2719-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,16]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2719"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2719-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,16]]},"article-number":"623"}}